Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 203Brain Neoplasms 94Gliosarcoma 93Glioma 88Central Nervous System Neoplasms 78Astrocytoma 66Oligodendroglioma 45Melanoma 37Medulloblastoma 18Neuroblastoma 17Neoplasm Metastasis 14Ependymoma 13Neoplasms 10Choroid Plexus Neoplasms 10Sarcoma 9Recurrence 9Optic Nerve Glioma 9Familial ependymoma 9Carcinoma, Non-Small-Cell Lung 9Ovarian Neoplasms 8Lung Neoplasms 8Spinal Cord Neoplasms 7Breast Neoplasms 7Uveal Melanoma 6Sarcoma, Ewing 6Rhabdoid Tumor 6Pinealoma 6Neuroectodermal Tumors, Primitive 6Unspecified Adult Solid Tumor, Protocol Specific 5Small Cell Lung Carcinoma 5

Interventions

entinostat 3Carboplatin 3Pemetrexed 2Bronchoscopy 2sotorasib 1pralsetinib 1pembrolizumab 1osimertinib 1lorlatinib 1ficlatuzumab 1exemestane 1demcizumab 1cobimetinib 1camrelizumab 1aflibercept 1Tyrosine Kinase Inhibitors 1Thrombin 1Temozolomide 1TachoSil 1Saline Solution 1Radiomics 1Paclitaxel 1One-Lung Ventilation 1Nutritional Status 1Microscopy, Confocal 1Gefitinib 1Fibrinogen 1Exercise 1Erlotinib Hydrochloride 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Diseases × Temozolomide × Clear all
NCT00249964 2016-01-20

Combination Paclitaxel, Carboplatin and Temozolomide

New Mexico Cancer Research Alliance

Phase 1 Completed
15 enrolled

Lung Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡